Gastroenterology Studies

Uncovering the colorectal cancer immunotherapeutic potential: Evening primrose (Oenothera biennis) root extract and its active compound oenothein B targeting the PD-1/PD-L1 blockade.

Immune checkpoint inhibitors (such as PD-L1/PD-1 blockers) are effective immunotherapy drugs for cancer treatment, but their side effects restrict their use. FDA only permits monoclonal antibody-based PD-L1/PD-1 blockers.

Lee EJ et al (2024).
Phytomedicine.
PubMed:
38266440

Daily Cashew and Brazil Nut Consumption Modifies Intestinal Health in Overweight Women on Energy-Restricted Intervention: A Randomized Controlled Trial (Brazilian Nuts Study).

Researchers studied the relationship between obesity, intestinal health, and the consumption of nuts. They found that nuts can improve gut health, reduce inflammation, and enhance the benefits of weight loss.

Souza Silveira BK et al (2024).
J Nutr.
PubMed:
38246355

Triptolide induces apoptosis and cytoprotective autophagy by ROS accumulation via directly targeting peroxiredoxin 2 in gastric cancer cells.

Triptolide, an active compound from Tripterygium wilfordii, kills gastric cancer cells by increasing reactive oxygen species (ROS) levels. It targets peroxiredoxins-2 (PRDX2) to inhibit its antioxidant activity, leading to apoptosis. PRDX2 could be a potential therapeutic target for anti-gastric cancer agents.

Chen P et al (2024).
Cancer Lett.
PubMed:
38246224